Cancer Vaccine Dose and Immunization Schedule Optimization Services

What Dose And Schedule Optimization Covers

Dose and immunization schedule optimization is a preclinical service for cancer vaccine programs that need a clearer view of how dose level and dosing interval relate to the immune readouts you plan to measure. Rather than committing early to a single regimen, projects compare a small set of scoped dose groups and immunization schedules under one study design, so that the resulting data can inform which regimens merit further work.

Engagements are built around your candidate, your model system, and the readouts that matter to your program. During scoping, typical projects define the dose levels, immunization intervals, group sizes, and sampling timepoints for the study, and the agreed schedule is then carried out with documented handling and reporting. The service is intended for research-stage evaluation and does not by itself establish clinical efficacy or predict clinical outcomes; findings are interpreted within the limits of the study design and are reported as project-specific results.

Comparative antigen-specific T cell response assays can support interpretation of immune responses across dose and schedule groups.

What the Service Can Include

Dose-Level Comparison

Scoped comparison of a defined set of dose levels for your vaccine candidate, with group allocation, dosing records, and readouts agreed during study design. The number of dose groups and the dose range are set per project based on your candidate and prior data.

Immunization Schedule Design

Evaluation of immunization intervals and repeat-administration schedules, including prime and boost timing where relevant to your program.

Readout And Sampling Planning

Selection of sampling timepoints and immune readouts appropriate to the questions you want addressed, such as humoral or cell-mediated measures, with the final readout panel confirmed as part of the project scope.

Model And System Selection Support

Discussion of suitable preclinical model systems and study conditions for your candidate during scoping, so that the chosen design is compatible with the readouts and comparisons you need.

How a Dose And Schedule Optimization Project Runs

Scoping and Study Design We review your candidate, available data, and program questions, then agree on dose levels, immunization schedules, group sizes, readouts, and timepoints. The study plan and statement of work are confirmed before any work begins.

Study Setup and Scheduling Model systems, materials, and group allocation are prepared according to the approved plan, and the immunization and sampling calendar is fixed so that dosing and collection timepoints are tracked against the agreed schedule.

Execution and Sample Collection The agreed dosing and immunization schedule is carried out with documented records, and samples are collected at the planned timepoints for the readouts defined in the study plan.

Readout Assessment and QC Samples are assessed using the agreed methods, with run-level checks and documentation appropriate to those methods. Results are reviewed for consistency before reporting, and any deviations from the plan are recorded.

Project Deliverables

Deliverable	What You Receive
Dose and schedule optimization plan	A written study plan defining dose levels, dosing intervals, immunization schedule options, and the readouts to be collected, agreed with your team before execution begins.
Immunization and sampling records	Documented administration records and sample collection logs for each study group, with deviations noted and tracked through the project.
Immunogenicity readout dataset	Quantified results from the assay panel selected during scoping, delivered as a structured dataset with group-level summaries and analysis-ready tables.
Dose–response and schedule comparison summary	A comparative summary of readouts across dose levels and schedule arms, presented with the caveat that findings are study-specific and do not by themselves establish clinical efficacy.
QC and assay performance documentation	Assay-level QC records covering controls, acceptance criteria, and run performance, so results can be reviewed with full traceability.

Why Teams Choose This Service

Schedule design treated as a first-class variable

Dose selection and immunization schedule are optimized together rather than sequentially, so interval and number of administrations are evaluated as design variables alongside dose level. This helps teams avoid carrying an untested schedule assumption into later development.

Scoped to your stage of development

Engagements are defined case by case after consultation. Early exploratory work can focus on a small number of dose and schedule arms, while later programs can add broader readout panels and additional comparison groups. Scope, group numbers, and validation depth are fixed in the project statement of work.

Decision-oriented reporting

Deliverables are structured around the decisions you need to make: which dose to carry forward, which schedule to test next, and where readouts were inconclusive. Reports separate assay-level QC findings from study-level interpretation so conclusions are not overstated.

Research reference

1. Sequential STING and CD40 agonism drives massive expansion of tumor-specific T cells in liposomal peptide vaccines

Cellular & Molecular Immunology. 2025. DOI: 10.1038/s41423-024-01249-4.

View article

Plan a Dose and Schedule Optimization Study

Share your vaccine candidate, target indication, and the questions you need answered about dose level and immunization timing. Our team will outline a scoped study design, the readouts to be collected, and the deliverables you can expect before work begins.

The comparison can also include cytokine release assays when cytokine responses are relevant to schedule selection.

Request a Scoping Discussion